| Document Date: 2015-05-17 18:47:21
Open Document File Size: 143,03 KBShare Result on Facebook
City TOKYO / New Orleans / SAN FRANCISCO / / Company AEs / Astellas Pharma Inc. / Prostate Cancer Working Group / Medivation Inc. / / Country United States / / / Event Business Partnership / / Facility University of Washington / Laboratory Abnormalities / / IndustryTerm treatment of these diseases / biopharmaceutical / pharmaceuticals / manufacturing / pharmaceutical / / MedicalCondition loss of consciousness / hypertension / disease / headache / arthralgia / dyspnea / neutropenia / vertigo / thrombocytopenia / metastatic castration-resistant prostate cancer / seizure / fatigue / diseases / diarrhea / infection / dizziness / prostate cancer / constipation / Infections / back pain / breast cancer / respiratory tract infection / injuries / / MedicalTreatment innovative therapies / chemotherapy / hormone therapy / / Organization University of Washington / U.S. Food and Drug Administration / AMERICAN UROLOGICAL ASSOCIATION / / Person Celestia S. Higano / Tyler Marciniak / / / Position Chief Financial Officer / investigator / Director / Communications and Advocacy / leader / Manager / Investor Relations / professor / medicine and urology / Director / Investor Relations / / Product bicalutamide / / ProvinceOrState Louisiana / / Technology chemotherapy / / URL www.fda.gov/medwatch / www.XtandiHCP.com / www.medivation.com / www.astellas.com/en / /
SocialTag |
Microsoft Word - AUA Data Press Release.Eg.FIN.docx